Estate Counselors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,270
| Closed | -$293K | – | 129 |
|
2023
Q1 | $293K | Buy |
+2,270
| New | +$293K | 0.04% | 120 |
|
2022
Q4 | – | Sell |
-1,390
| Closed | -$162K | – | 160 |
|
2022
Q3 | $162K | Sell |
1,390
-920
| -40% | -$107K | 0.03% | 119 |
|
2022
Q2 | $271K | Buy |
+2,310
| New | +$271K | 0.04% | 113 |
|
2022
Q1 | – | Sell |
-1,250
| Closed | -$190K | – | 169 |
|
2021
Q4 | $190K | Sell |
1,250
-1,973
| -61% | -$300K | 0.02% | 120 |
|
2021
Q3 | $521K | Sell |
3,223
-50,105
| -94% | -$8.1M | 0.07% | 118 |
|
2021
Q2 | $8.72M | Buy |
53,328
+5,960
| +13% | +$974K | 1.14% | 31 |
|
2021
Q1 | $7.13M | Buy |
47,368
+23,068
| +95% | +$3.47M | 1.04% | 35 |
|
2020
Q4 | $3.68M | Sell |
24,300
-465
| -2% | -$70.4K | 0.55% | 48 |
|
2020
Q3 | $3.35M | Buy |
24,765
+1,155
| +5% | +$156K | 0.52% | 46 |
|
2020
Q2 | $3.23M | Sell |
23,610
-83,130
| -78% | -$11.4M | 0.52% | 45 |
|
2020
Q1 | $11.5M | Buy |
106,740
+1,250
| +1% | +$135K | 1.89% | 15 |
|
2019
Q4 | $12.7M | Buy |
+105,490
| New | +$12.7M | 1.87% | 20 |
|
2019
Q2 | – | Sell |
-153,300
| Closed | -$17.1M | – | 69 |
|
2019
Q1 | $17.1M | Buy |
153,300
+39,400
| +35% | +$4.4M | 2.94% | 9 |
|
2018
Q4 | $11M | Sell |
113,900
-5,200
| -4% | -$501K | 2.22% | 16 |
|
2018
Q3 | $14.5M | Buy |
119,100
+42,210
| +55% | +$5.15M | 2.63% | 14 |
|
2018
Q2 | $8.44M | Buy |
76,890
+3,950
| +5% | +$434K | 1.6% | 23 |
|
2018
Q1 | $7.79M | Buy |
72,940
+10,000
| +16% | +$1.07M | 1.45% | 25 |
|
2017
Q4 | $6.72M | Sell |
62,940
-22,560
| -26% | -$2.41M | 1.34% | 31 |
|
2017
Q3 | $9.51M | Buy |
85,500
+34,500
| +68% | +$3.84M | 1.89% | 24 |
|
2017
Q2 | $5.27M | Buy |
51,000
+18,000
| +55% | +$1.86M | 1.19% | 31 |
|
2017
Q1 | $3.23M | Hold |
33,000
| – | – | 0.84% | 37 |
|
2016
Q4 | $2.92M | Buy |
+33,000
| New | +$2.92M | 0.81% | 45 |
|